Familial hypercholesterolemia cascade testing: Insights from the Dutch Program

J Clin Lipidol. 2026 Sep 4:S1933-2874(26)00503-9. doi: 10.1016/j.jacl.2026.08.027. Online ahead of print.ABSTRACTBACKGROUND AND OBJECTIVE: Familial hypercholesterolemia (FH) is a prevalent genetic disorder causing lifelong elevated LDL-cholesterol and premature cardiovascular disease. After the Dutc

B Bram M Weijs

CKM: Epidemiology, current clinical implications and future burden

Eur J Intern Med. 2026 Sep 18:107197. doi: 10.1016/j.ejim.2026.107197. Online ahead of print.ABSTRACTCardiovascular-kidney-metabolic (CKM) syndrome was formalized by the American Heart Association in 2023 to capture the biological and clinical continuum linking excess adiposity, metabolic dysfunctio

E Elisa Russo

In situ exploration of endothelial function in vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass: protocol for a single-centre prospective cohort study - the Vasoshock study

BMJ Open. 2026 Sep 18;16(9):e122692. doi: 10.1136/bmjopen-2026-122692.ABSTRACTINTRODUCTION: Vasoplegic syndrome (VS) is a severe complication after cardiac surgery with cardiopulmonary bypass (CPB), characterised by vasodilation, hypotension and vasopressor dependence. Endothelial dysfunction, dysre

N Nicolas Ferry

Effect of fish oil as an adjunct therapy to metformin on vascular and cardiac health in women with polyendocrine metabolic ovarian syndrome: protocol for a randomised, placebo-controlled clinical trial

BMJ Open. 2026 Sep 18;16(9):e124025. doi: 10.1136/bmjopen-2026-124025.ABSTRACTINTRODUCTION: Polyendocrine metabolic ovarian syndrome (PMOS) (formerly known as polycystic ovary syndrome) is a metabolic-endocrine disorder that affects 8-13% of women globally and is associated with increased cardiovasc

B Beate Sydora